Fatty Acids of Value in Anxiety

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Dr Linda Calabresi

The value of omega-3 fatty acids has come under fire lately. But now a new systematic review suggests they might have benefits beyond the previous therapeutic targets of depression, cardiac health, eye health and arthritis.

Researchers have found that omega-3 polyunsaturated fatty acids (PUFA) might reduce the symptoms of clinical anxiety, particularly among those people who had a specific clinical condition be it medical (such as Parkinson disease) or psychological (premenstrual syndrome).

“This systematic review…provides the first meta-analytic evidence, to our knowledge, that omega-3 PUFA treatment may be associated with anxiety reduction, which might not only be due to a potential placebo effect, but also from some associations of treatment with reduced anxiety symptoms,” the review authors said in JAMA.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Deborah Bateson AM

Prof Deborah Bateson AM

The Natural Estrogen Debate: A Focus on Combined Oral Contraception

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes

Dr Gabby Mahoney

Dr Gabby Mahoney

Eczema Management Practical Tips

Prof Rodney Baber AM

Prof Rodney Baber AM

Menopausal Hormone Therapy and its Cardiovascular Benefits

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Test your knowledge

Recent articles

Latest GP poll

The government's bulk billing incentives start on 1 November. How accurate do you think the government's messaging to the public has been?

Very misleading

0%

Moderately misleading

0%

Slightly misleading

0%

Not at all misleading

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Panel discussion on GLP1s for chronic kidney disease in type 2 diabetes

TONIGHT Tuesday 28th October, 7pm - 9pm AEDT

Panellists

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Paediatric Allergist and Immunologist; Royal Children's Hospital

We invite you to our next free webcast, where an expert panel will discuss GLP1s for CKD in T2D. Up to 4 hours CPD. RACGP & ACRRM accredited.